2017
DOI: 10.15407/cryo27.04.334
|View full text |Cite
|
Sign up to set email alerts
|

Cardiomyocyte Ultrastructure of Rats with Experimental Myocardial Infarction After Therapeutic Hypothermia and Mesenchymal Stromal Cell Administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 5 publications
0
2
0
1
Order By: Relevance
“…Therapeutic hypothermia was performed in a cold chamber, 60 minutes long. The local skin temperature of the neck area was maintained at +4 о C, while the rectal and tympanic temperature decreased to +25 о C [8].…”
Section: Methodsmentioning
confidence: 98%
See 1 more Smart Citation
“…Therapeutic hypothermia was performed in a cold chamber, 60 minutes long. The local skin temperature of the neck area was maintained at +4 о C, while the rectal and tympanic temperature decreased to +25 о C [8].…”
Section: Methodsmentioning
confidence: 98%
“…Терапевтичну гіпотермію проводили в холодовій камері протягом 60 хв. Температура шкіри комірцевої зони -+4 о С, ректальна і тимпанічна температура знижувалася до +25 о С [8].…”
Section: Methodsunclassified
“…A displacement of myofibrillar mitochondria into the sarcolemmal zone of cardiomyocytes was noted. The swelling of mitochondria and the formation of large vacuoles in their matrix are the most common changes in the ultrastructural organization of mitochondria [30][31][32]. As for the MLBs occurring in HR heart mitochondria, there are studies demonstrating that the mitochondrial membrane material can be used to form a developing autophagosome both in the norm and in pathology [33].…”
mentioning
confidence: 99%
“…Coexistence of cardiovascular diseases and metabolic disorders, namely type 2 diabetes mellitus (type 2 DM), is one of the most commonly occurring comorbidities and is the main cause of death at an earlier stage of the disease [3,4]. Hemostatic impairments [5], along with metabolic disorders, occupy key positions in the development of cardiovascular pathology in type 2 DM. Assessment of mortality structure provides the most objective illustration of this connection: thrombosis is the cause of death in 80 % of patients with type 2 DM, 75 % of which are of coronary localization, 25 % is cerebrovascular and peripheral thrombosis [4].…”
mentioning
confidence: 99%